Update on Insulin Management in Type 2 Diabetes-Reference-Cited by-同舟云学术

Update on Insulin Management in Type 2 Diabetes

Published:2009-01-01 Issue:2 Volume:22 Page:85-91
ISSN:1040-9165
Container-title:Diabetes Spectrum
language:en
Short-container-title:

Author:

Neumiller Joshua J.,Odegard Peggy Soule,Wysham Carol H.

Abstract

In Brief This article provides a brief overview of the various insulin products currently available on the market and discusses considerations regarding insulin therapy in people with type 2 diabetes. Issues involving the initiation, titration, and optimization of insulin therapy to meet individual patient treatment goals are discussed.

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/spectrum/article-pdf/22/2/85/503621/85.pdf

Reference35 articles.

1. Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulin;Chan;Mayo Clin Proc,2003

2. When oral agents fail: practical barriers to starting insulin;Korytkowski;Int J Obes Relat Metab Disord,2002

3. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study;Peyrot;Diabetes Care,2005

4. Medical guidelines for clinical practice for the management of diabetes mellitus;American College of Endocrinology/American Association of Clinical Endocrinologists;Endocr Pract,2007

5. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus;Garvey;Diabetes,1985

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of New Valinol‐Derived Sultam Triazoles as α ‐Glucosidase Inhibitors;ChemistrySelect;2021-10

2. Emerging technologies for the management of type 2 diabetes mellitus;Journal of Diabetes;2021-05-11

3. Dibenzazepine-linked isoxazoles: New and potent class of α-glucosidase inhibitors;Bioorganic & Medicinal Chemistry Letters;2021-05

4. Efficacy and Safety of Intramuscular Insulin Lispro vs. Continuous Intravenous Regular Insulin for the Treatment of Dogs With Diabetic Ketoacidosis;Frontiers in Veterinary Science;2020-10-16

5. Intensification to injectable therapy in type 2 diabetes: mixed methods study (protocol);BMC Health Services Research;2019-05-03